Hypertriglyceridemia as a risk factor for coronary heart disease - an an-giographic study;Hypertriglyzeridämie als Risikofaktor für Koronare Herzkrankheit -eine koronarangiographische Studie

Herz Kreislauf

Volumn 28, Issue 9, 1996, Pages 282-284

  Germing, A ^a   Machraoui, A ^a   Poller, W ^a   Braun, B E ^a   Barmeyer, J ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Coronary heart disease; Lipids; Risk factors; Triglycerides

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; STATISTICAL ANALYSIS;

EID: 0029812379     PISSN: 00467324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Albrink, M. J., Man. E. B.: Serum triglycerides in coronary artery disease. Arch. Intern. Med. 103, 4-8 (1959)
2. A.ssmann, G., Schulte, H.: The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hypcrlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am. Heart J. 116. 1713-1724 (1988)
3. Austin. M. A.: Plasma triglycéride as a risk factor for coronary heart disease. Am. J. Epidemiol. 129, 249-259 (1989)
4. Austin, M. A.: Plasma triglycéride and coronary heart disease. Arterioscler. Thromb. II. 2-14 (1991)
5. Barbir, M., Wile, D., Trayner, I., Aber, V. R., Thompson, G. R.: High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Br. Heart. J. 60, 397-403 (1988)
6. Bradley. W. A., Booyse, F. M., Gianturco, S. H.: Fibrinolytic and thrombotic factors in atherosclerosis and IHD: the influence of triglycéride rich lipoproteins (TGRLP). Atherosclerosis 108 (Suppl.), S.31-39(1994)
7. Bradley, W. A., Gianturco, S. H.: Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. J. Intern. Med. Suppl. 736, S. 33-39 (1994)
8. Brown, D. F., Kinch, S. H., Doyle, J. T.: Serum triglycérides in health and in ischémie heart disease. New Engl. J. Med. 273, 947-952 (1965)
9. Cambien, F., Jaqueson, A., Richard, J. L., Warnet, J. M., Ducimetiere, P., Claude, J. R.: Is the level of serum triglycéride a significant predictor of coronary death in normocholesterolemic subjects ? The Paris Prospective Study. Am. J. Epidemiol. 124, 624-632 (1986)
10. Carlson, L. A., Böttiger, L. E.: Ischaemic heart-disease in relation to fasting values of plasma triglycérides and cholesterol: Stockholm prospective study. Lancet 1, 865-868 (1972)
11. Carlson, L. A., Böttiger, L. E., Alsfeldt, P. E.: Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focussing on the role of plasma triglycérides and cholesterol. Acta Med. Scand. 206, 351-360 (1980)
12. Carlson, L. A., Rosenhamer, G.: Reduction of mortality in the Stockholm ischémie heart disesease secondary prevention study by combined treatment with clofibrate and nicotinic acid. Acta Med. Scand. 223,405-418 (1988)
13. Castelli, W. P.: The triglycéride issue: A view from Frarningham. Am. Heart J. 112, 432-437 (1986)
14. Cramer, K., Paulin, S., Werko, L.: Coronary angiography findings in correlation with age, body weight, blood pressure, serum lipids, and smoking habits. Circulation 33, 888-900 (1966)
15. Freedman, D. S., Gruchow, H. W., Anderson, A. J., Rimm, A. A., Barboriak. J. J.: Relation of triglycéride levels to coronary artery disease: the Milwaukee cardiovascular Data Registry. Am. J. Epidemiol. 127, 1118-1130(1988)
16. Genest, J., McNamara, J. R., Ordovas, J. M., Jenner, J. L., Silberman, S. R., Anderson, K. M., Wilson, P. W. F., Salem, D. N., Schaefer, E. J.: Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein(a) abnormalities in men with premature coronary artery disease. J. Am. Coll. Cardiol. 19, 792-802(1992)
17. Geurian. K., Pinson, J. B., Weart, C. W.: The triglycéride connection in atherosclerosis. Ann. Pharmaeother. 26, 1109-1117 (1992)
18. Heyden. S.: Welche Bedeutung haben die Triglyzeride in der Atherogenese ? Thcrapiewoche 41. 670-677 (1991)
19. Hulley. S. B., Rosenman, R. H., Bawol, R. D., Brand, R. J.: The association between triglycéride and coronary heart disease. New Engl. J. Med. 302. 1383-1389 (1980)
20. Kannel, W. B., Castelli, W. P., Gordon, T., McNa mara. P. M.: Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham Study. Ann. Intern. Med. 74, 1-12 (1971)
21. Kannel. W. B., Castelli, W. B., Gordon, T: Cholesterol in the prediction of atherosclerotic disease. Ann. Intern. Med. 90, 85-91 (1979)
22. Kwiterovich, P. O., Coresh, J., Smith, H. H., Baehorik, P. S., Derby, C. A., Pearson, T. A.: Comparison of the plasma levels of apolipoprotcins B and
23. A-1, and other risk factors in men and women with premature coronary artery disease. Am. J. Cardiol. 69, 1015-1021 (1992)
24. Manninen, V., Tckaanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., Frick. M. H.: Joint effects of serum triglycéride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 85, 37-45 (1992)
25. Miller, G. J.: Lipoproteins and the haemostatic system in atherothrombotic disorders. Baillicres Clin. Haematol. 7, 713-732 (1994)
26. Nikkila. M., Koivula, T., Niemelä, K., Sisto, T.: High density lipoprotein cholesterol and triglycérides as markers of angiographically assessed coronary artery disease. Br. Heart. J. 63, 78-81 (1990)
27. Patsch, J. R.: Triglyceride-rich lipoproteins and atherosclerosis. Atherosclerosis 110 (Suppl.), 5.23-26(1994)
28. Pelkonen, R., Nikkila. E. A., Koskinen, S., Penttinen, K., Sarna, S.: Association of serum lipids and obesity with cardiovascular mortality. Br. Med. J. 2, 1185-1187 (1977)
29. Rosenman, R. H., Friedman, M., Straus, R., Jenkins, C. D., Zyzynski, S. J., Wurm, M.: Coronary heart disease in the Western Collaborative Group Study. J. Chronic Dis. 23, 173-190 (1970)
30. Rosenman, R. H., Brand. R. J., SchollJ., R. I., Friedman, M.: Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group Study. Am. J. Cardiol. 37. 903-910(1976)
31. Simpson, H. C. R., Meade, T. W., Stirling, Y., Mann, J. L., Chakrabarti, R., Woolf, L.: Hypertriglyceridaemia and hypercoagulability. Lancet 1, 786-789 (1983)
32. Tallis, G. A.: Atherogenecity of triglyceride-rich lipoproteins. J. Cardiovasc. Risk. I, 202-206 (1994)
33. Tibblin, G., Wilhelmsen, L., Werkö, L.: Risk factors for myocardial infarction and death due to ischémie heart disease and other causes. Am. J. Cardiol. 35. 514-522 (1975)
34. Tverdal. A., Foss. O. P., Leren, P., Holme. I., LundLarsen. P. G., Bjartveit, K.: Serum triglycéride as an independent risk factor for death from coronary heart disease in middle-aged norwegian men. Am. J. Epidemiol. 129, 458-465 (1989)
35. Wilhelmsen, L., Wedel, H., Tibblin, G.: Multivariate analysis of risk factors for coronary heart disease. Circulation 48, 950-958 (1973)
36. Zilversmit, D. B.: Atherogenic nature of triglycérides, postprandial lipidemia, and triglyceriderich remnant lipoproteins. Clin. Chem. 41, 153-158 (1995)